Dianthus Therapeutics Inc Sustainability Reports
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on designing and developing selective monoclonal antibody complement therapies for patients suffering from severe autoimmune diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Z3N6ODPCOFC890
FIGI: BBG00FB2NQ15
1 reports from 2023 to 2023
